The challenge of diagnosing Multisystem Inflammatory Syndrome in Children (MIS-C), a comparison of criteria in a single center cohort

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00038252

Enrollment

Registered

2025-11-27

Start date

2025-10-30

Completion date

Unknown

Last updated

2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multisystem inflammatory syndrome in children (MIS-C)

Interventions

Group 1: All children aged 18 years or younger with a suspected diagnosis of multisystem inflammatory syndrome in children (MIS-C) who fell ill between March 2021 and August 2022 and are being treated

Eligibility

Sex/Gender

All

Age

No minimum to 18 Years

Inclusion criteria

Inclusion criteria: Clinical and laboratory signs of hyperinflammation

Exclusion criteria

Exclusion criteria: Congenital heart disease or existing heart failure.

Design outcomes

Primary

Measure	Time frame
Difference in diagnosis based on updated criteria	—

Secondary

Measure	Time frame
Different treatment recommendations	—

Countries

Germany

Contacts

Public ContactMarkus Dechant

KUNO Kinderklinik Regensburg Standort Klinik St. Hedwig

markus.dechant@barmherzige-regensburg.de+499413695801

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026